Oliver Lieleg on DNA strands in nano-controlled drug release

Written by The Nanomed Zone, Oliver Lieleg (Technical University of Munich)
Interviews Nanomedicine
Pharmacogenomics

As an expert in bioengineering and drug discovery, Oliver Lieleg spoke to us about his recent innovative work on the use of DNA strands in a nano-based drug delivery tool which could be applied in delivery medicines for many human diseases.   Biography: Oliver Lieleg studied biophysics at the Technical University of Munich (TUM, Germany) where he obtained his PhD in 2008. After a postdoctoral stay at Harvard University (MA, USA) and Massachusetts Institute of Technology (MIT; MA, USA) he returned to TUM in 2011, where he has been Associate Professor in the Department of Mechanical Engineering since. Prof. Lieleg’s...

To view this content, please register now for access

Join our member community for FREE to access a collection of journal and online-only features, including:

  • Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
  • The latest news and journal updates delivered straight to your inbox when you want it
  • Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
  • Priority registration to webinars, panel discussions and events
  • Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!